Bay Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bay Capital Advisors's LLY Position: Q3 2026 in Review
Bay Capital Advisors reduced its Eli Lilly (LLY) stake by 1.4% in Q3 2026, selling an estimated $23.6K and leaving 1,446 shares worth $1.67M. The position accounts for 0.89% of the portfolio, ranked #22.
Bay Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.76M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bay Capital Advisors held 1,446 shares of Eli Lilly worth $1.67M as of Q3 2026.
- Bay Capital Advisors sold 20 Eli Lilly shares in Q3 2026, an estimated $23.6K.
- Eli Lilly made up 0.89% of Bay Capital Advisors's portfolio in Q3 2026, its #22 holding.
- Bay Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- Bay Capital Advisors's Eli Lilly position peaked at $1.76M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bay Capital Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.